Fred Aslan - President & CEO @ Artiva Biotherapeutics

Start Free Trial

Pricing

Overview

Number of Current Board & Advisor Roles

Number of Founded Organizations

Primary Job Title President & CEO
Primary Organization
Artiva Biotherapeutics

Location San Francisco, California, United States
Regions San Francisco Bay Area, West Coast, Western US
Gender Male

Investor Type
obfuscated
obfuscation

LinkedIn View on LinkedIn

Fred Aslan is based out of San Francisco, California and is the President & CEO of Artiva Biotherapeutics. Fred previously worked at Vividion Therapeutics as a President and Chief Business Officer. Fred Aslan attended Duke University.

Partner Investments

Number of Partner Investments

Announced Date	Organization Name	Investor Name	Lead Investor	Funding Round	Money Raised
obfuscated obfuscation	Receptos	Venrock	No	Venture Round - Receptos	obfuscated obfuscation
obfuscated obfuscation	Receptos	Venrock	Yes	Series A - Receptos	obfuscated obfuscation

Jobs

Number of Current Jobs

Number of Past Jobs

Fred Aslan

has

current jobs as

President & CEO

Artiva Biotherapeutics

and

Founder & Chief Executive Officer

Adavium

. Additionally,

Fred Aslan

has had

past jobs including

President and Chief Business Officer

Vividion Therapeutics

Artiva Biotherapeutics President & CEOJan 5, 2021
Adavium Founder & Chief Executive OfficerJan 2011

Organization Name	Title At Company	Start Date	End Date
Vividion Therapeutics	President and Chief Business Officer	Sep 18, 2018	Jan 2021
Venrock	Vice President	Jun 2006	2018
Curagen Corporation	Director of Business Development and Lead Investor Relations	May 2002	May 2005
The Boston Consulting Group	Strategy Consultant	Sep 2000	May 2001
Receptos	Co-Founder	—	—

Board and Advisor Roles

Number of Current Board & Advisor Roles

Number of Past Board & Advisor Roles

Fred Aslan

holds

board and advisor roles as

Member of the Board of Directors

BayBrazil

and

Member of the Board of Directors

Adavium

BayBrazil Member of the Board of DirectorsJul 2011
Adavium Member of the Board of Directors

Organization Name	Title At Company	Start Date	End Date
Receptos	Member of the Board of Directors	—	—

Related Hubs

Hub Name	CB Rank (Hub)
United States Therapeutics Companies (Top 10K)	5,823
Blue Owl Portfolio Companies	63,156
5AM Ventures Portfolio Companies	67,731
Therapeutics Public Companies With Fewer Than 1000 Employees	15,367
California Life Science Companies	43,581
Biotechnology Public Companies With Fewer Than 1000 Employees	7,610
Life Science Companies With More Than 10 Employees	7,887
West Coast Public Companies With Fewer Than 1000 Employees	99,965
United States Public Companies With Fewer Than 1000 Employees	4,226
West Coast Therapeutics Companies	20,667

Education

Fred Aslan

studied at

Duke University

Yale University

, and

Harvard Business School

Duke University BSBiology, General19931997
Yale University MD19972001
Harvard Business School MBA20042006